Eli Lilly and Co

Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the…

Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its…

In the lucrative obesity drug race, there is Eli Lilly — and then there’s everybody else. A pair…

Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most…

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March…

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark,…

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET.…

Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it…

Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major…

Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025. Antranik…

Boxes of the drug trulicity, made by Eli Lilly and Company, sit on a counter at a pharmacy…

Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly